Eli Lilly & Co. is acquiring Orna Therapeutics for up to $2.4 billion, expanding its pipeline beyond obesity drugs. Meanwhile, analysis suggests China's biotech licensing boom is set to hit a record in [----].
Biotechnology is an interdisciplinary field that uses living organisms and biological systems to develop or create different products.
Engagements 24-Hour Time-Series Raw Data
Current Value: [---------]
Daily Average: [---------]
[--] Month: [----------] -61%
[--] Months: [-----------] +150%
[--] Year: [-------------] +185%
1-Year High: [----------] on 2025-12-06
1-Year Low: [-------] on 2025-05-09
Engagements by network (24h): YouTube: [-------] X: [-------] TikTok: [-------] Instagram: [-----] News: [------] Reddit: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
1-Year High: [------] on 2025-11-13
1-Year Low: [-----] on 2025-03-16
Mentions by network (24h): YouTube: [-----] X: [-----] TikTok: [---] Instagram: [--] News: [--] Reddit: [---]
Creators 24-Hour Time-Series Raw Data
[-----] unique social accounts have posts mentioning Biotech in the last [--] hours which is down 2.80% from [-----] in the previous [--] hours
Daily Average: [-----]
1-Year High: [-----] on 2025-11-13
1-Year Low: [-----] on 2025-05-03
The most influential creators that mention Biotech in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @yzilabs | [--] | [-------] | [--] | [------] |
| @Rainmaker1973 | [--] | [---------] | [--] | [------] |
| @BiopharmIQ | [--] | [------] | [--] | [------] |
| @Biotech2k1 | [--] | [------] | [--] | [-----] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 86%
Daily Average: 81%
[--] Month: 83% -2%
[--] Months: 83% -9%
[--] Year: 83% -6%
1-Year High: 98% on 2025-08-24
1-Year Low: 34% on 2025-11-04
Most Supportive Themes:
Most Critical Themes:
Top news links shared on social in the last [--] hours
Showing a maximum of [--] news posts without a LunarCrush subscription.
"Analysis-China biotech licensing boom to hit record in [----] as pipeline swells By Kane Wu and Andrew Silver HONG KONG/SHANGHAI Feb [--] (Reuters) - Global drugmakers are stepping up their search for Chinadeveloped experimental medicines as they cut costs ahead of patent"
News Link @YahooFinance 2026-02-15T14:26Z 2M followers, [----] engagements
"De Masi: Quantum systems will be far more energy efficient than classical AI Niccolo De Masi Chairman and Chief Executive Officer of IonQ says quantum computing is advancing faster than expected with rapid gains in qubits major efficiency advantages and near term applications in AI biotech and national security"
News Link @CNBCi 2026-02-09T23:44Z 181.8K followers, 33K engagements
"Lilly Strikes Deal for Orna Therapeutics for Up to $2.4 Billion - Bloomberg Eli Lilly & Co agreed to buy closely held US biotech Orna Therapeutics Inc. for up $2.4 billion in cash its second deal in as many days as the company expands its pipeline beyond its well-known blockbuster obesity drug Zepbound"
News Link @business 2026-02-09T12:18Z 9.8M followers, 17.9K engagements
"Big Pharma race to snap up biotech assets as $170 billion patent cliff looms Companies are facing a situation where they need to fill their pipelines but also navigate a competitive environment for the best assets"
News Link @CNBCi 2026-01-07T07:44Z 181.8K followers, 56.5K engagements
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"This is the relationship of the junkier Russell [----] small cap index versus the higher quality S&P [---] small cap index. Over a full cycle the S&P [---] has materially outperformed the Russell [----]. But from the [----] low to late [----] the junkier Russell [----] outperformed the profitable S&P [---]. Now the Russell [----] has started underperforming again as junk unwinds biotech wipes out and unprofitable tech implodes. I expect this ratio to continue falling well below the [----] low as higher quality profitable small caps outperform the junkier science projects"
X Link @Greenbackd 2026-02-17T20:52Z 70.4K followers, [----] engagements
"Breaking barriers in biotechnology starts with access. EXOT is building a permissionless framework that helps accelerate life-saving discoveries while making innovation open to everyone not just a few. Our mission is clear: become the trusted financial infrastructure powering the next generation of biotech innovation. 🧬✨ #biotech #RWA #BSC #DeFi"
X Link @ExotProject 2026-02-17T20:03Z 16.2K followers, [----] engagements
"Started two new stock positions today - first additions in a while. Both are 1% starter positions and already shared in my X Sub. Even when equity indices look stretched there are always selective single-name opportunities. You just have to be disciplined and patient. Portfolio remains defensive - bonds as ballast. Longs: Real businesses. Real cash flow. Or asymmetric biotech setups with defined risk/reward. Shorts: Where hype still far exceeds fundamentals - especially in quantum and nuclear. [----] delivered 75%. Now the focus is making [----] even better. Let's lock in"
X Link @commonsenseplay 2026-02-17T19:06Z 26.3K followers, [----] engagements
"$IOVA - This Luna calendar year is the year of the horse. We have been waiting"
X Link @BIOTECHSCANNER 2026-02-17T18:42Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing